Costs and outcomes of the German disease management programme (DMP) for chronic obstructive pulmonary disease (COPD)—A large population-based cohort study

Health Policy

Volumn 120, Issue 9, 2016, Pages 1029-1039

  Achelrod, Dmitrij ^a   Welte, Tobias ^b   Schreyögg, Jonas ^a   Stargardt, Tom ^a  

^a UNIVERSITY OF HAMBURG   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

COPD; Disease management programme (DMP); Health economic evaluation; Managed care

Indexed keywords

ADULT; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DISEASE MANAGEMENT PROGRAM; FEMALE; GERMANY; HAZARD RATIO; HEALTH CARE COST; HEALTH CARE UTILIZATION; HEALTH PROGRAM; HOSPITALIZATION; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEDICATION COMPLIANCE; MORBIDITY; MORTALITY; OUTCOME ASSESSMENT; PHARMACEUTICAL CARE; PRACTICE GUIDELINE; PRESCRIPTION; AGED; COMPLICATION; COST BENEFIT ANALYSIS; DISEASE MANAGEMENT; ECONOMICS; HEALTH SURVEY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RETROSPECTIVE STUDY;

AGED; COST-BENEFIT ANALYSIS; DISEASE MANAGEMENT; DRUG PRESCRIPTIONS; FEMALE; GERMANY; HOSPITALIZATION; HUMANS; LENGTH OF STAY; MALE; MEDICATION ADHERENCE; OUTCOME ASSESSMENT (HEALTH CARE); POPULATION SURVEILLANCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RETROSPECTIVE STUDIES;

EID: 84989910974     PISSN: 01688510     EISSN: 18726054     Source Type: Journal    
DOI: 10.1016/j.healthpol.2016.08.002     Document Type: Article

References (57)

1. Connors, A.F. Jr., Dawson, N.V., Thomas, C., Harrell, F.E. Jr., Desbiens, N., Fulkerson, W.J., et al. Outcomes following acute exacerbation of severe chronic obstructive lung disease. The SUPPORT investigators (Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments). American Journal of Respiratory and Critical Care Medicine 154 (1996), 959–967, 10.1164/ajrccm.154.4.8887592.
2. Groenewegen, K.H., Schols, A.M.W.J., Wouters, E.F.M., Mortality and mortality-related factors after hospitalization for acute exacerbation of COPD. Chest 124 (2003), 459–467.
3. Gudmundsson, G., Gislason, T., Lindberg, E., Hallin, R., Ulrik, C.S., Brøndum, E., et al. Mortality in COPD patients discharged from hospital: the role of treatment and co-morbidity. Respiratory Research, 7, 2006, 109, 10.1186/1465-9921-7-109.
4. Ng, T.-P., Niti, M., Tan, W.-C., Cao, Z., Ong, K.-C., Eng, P., Depressive symptoms and chronic obstructive pulmonary disease: effect on mortality, hospital readmission, symptom burden, functional status, and quality of life. Archives of Internal Medicine 167 (2007), 60–67, 10.1001/archinte.167.1.60.
5. Kuhl, K., Schurmann, W., Rief, W., Mental disorders and quality of life in COPD patients and their spouses. International Journal of Chronic Obstructive Pulmonary Disease 3 (2008), 727–736.
6. Rodriguez Gonzalez-Moro, J.M., de Lucas Ramos, P., Izquierdo Alonso, J.L., López-Muñiz Ballesteros, B., Antón Díaz, E., Ribera, X., et al. Impact of COPD severity on physical disability and daily living activities: EDIP-EPOC I and EDIP-EPOC II studies. International Journal of Clinical Practice 63 (2009), 742–750, 10.1111/j.1742-1241.2009.02040.x.
7. Wacker, M.E., Jörres, R.A., Schulz, H., Heinrich, J., Karrasch, S., Karch, A., et al. Direct and indirect costs of COPD and its comorbidities: results from the German COSYCONET study. Respiratory Medicine 111 (2016), 39–46, 10.1016/j.rmed.2015.12.001.
8. Decramer, M., Janssens, W., Miravitlles, M., Chronic obstructive pulmonary disease. The Lancet 379 (2012), 1341–1351, 10.1016/S0140-6736(11)60968-9.
9. Geldmacher, H., Biller, H., Herbst, A., Urbanski, K., Allison, M., Buist, A.S., et al. The prevalence of chronic obstructive pulmonary disease (COPD) in Germany. Results of the BOLD study. Deutsche Medizinische Wochenschrift 133 (2008), 2609–2614, 10.1055/s-0028-1105858.
10. Pritzkuleit, R., Beske, F., Katalinic, A., Disease numbers in pneumology—a projection to 2060. Pneumologie 64 (2010), 535–540, 10.1055/s-0030-1255637.
11. Bundesversicherungsamt Zulassung der strukturierten Behandlungsprogramme (Disease Management Programme—DMP) durch das Bundesversicherungsamt (BVA). 2014 http://www.bundesversicherungsamt.de/weitere-themen/disease-management-programme/zulassung-disease-management-programme-dmp.html [accessed 09.11.15].
12. Wagner, E.H., Austin, B.T., Davis, C., Hindmarsh, M., Schaefer, J., Bonomi, A., Improving chronic illness care: translating evidence into action. Health Affairs (Project Hope) 20 (2001), 64–78.
13. Ärztliches Zentrum für Qualität in der Medizin (ÄZG), Bundesärztekammer, Kassenärztliche Bundesvereinigung, AWMF. Nationale Versorgungsleitlinie COPD, vol. version 11. Langfassung. Ärztliches Zentrum für Qualität in der Medizin (ÄZG); 2013.
14. Kruis, A.L., Smidt, N., Assendelft, W.J.J., Gussekloo, J., Boland, M.R.S., Rutten-van Mölken, M., et al. Integrated disease management interventions for patients with chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews, 10, 2013, CD009437, 10.1002/14651858.cd009437.pub2.
15. Peytremann-Bridevaux, I., Staeger, P., Bridevaux, P.-O., Ghali, W.A., Burnand, B., Effectiveness of chronic obstructive pulmonary disease-management programs: systematic review and meta-analysis. American Journal of Medicine 121 (2008), 433–443, 10.1016/j.amjmed.2008.02.009 e4.
16. Taylor, S.J.C., Candy, B., Bryar, R.M., Ramsay, J., Vrijhoef, H.J.M., Esmond, G., et al. Effectiveness of innovations in nurse led chronic disease management for patients with chronic obstructive pulmonary disease: systematic review of evidence. BMJ, 331, 2005, 485, 10.1136/bmj.38512.664167.8F.
17. Sin, D.D., McAlister, F.A., Man, S.F.P., Anthonisen, N.R., Contemporary management of chronic obstructive pulmonary disease: scientific review. JAMA 290 (2003), 2301–2312, 10.1001/jama.290.17.2301.
18. Boland, M.R.S., Tsiachristas, A., Kruis, A.L., Chavannes, N.H., Rutten-van Mölken, M.P.M.H., The health economic impact of disease management programs for COPD: a systematic literature review and meta-analysis. BMC Pulmonary Medicine, 13, 2013, 40, 10.1186/1471-2466-13-40.
19. Lemmens, K.M.M., Nieboer, A.P., Huijsman, R., A systematic review of integrated use of disease-management interventions in asthma and COPD. Respiratory Medicine 103 (2009), 670–691, 10.1016/j.rmed.2008.11.017.
20. Mehring, M., Donnachie, E., Fexer, J., Hofmann, F., Schneider, A., Disease management programs for patients with COPD in Germany: a longitudinal evaluation of routinely collected patient records. Respiratory Care 59 (2014), 1123–1132, 10.4187/respcare.02748.
21. Lemmens, K.M.M., Lemmens, L.C., Boom, J.H.C., Drewes, H.W., Meeuwissen, J.A.C., Steuten, L.M.G., et al. Chronic care management for patients with COPD: a critical review of available evidence. Journal of Evaluation in Clinical Practice 19 (2013), 734–752, 10.1111/j.1365-2753.2011.01805.x.
22. Adams, S.G., Smith, P.K., Allan, P.F., Anzueto, A., Pugh, J.A., Cornell, J.E., Systematic review of the chronic care model in chronic obstructive pulmonary disease prevention and management. Archives of Internal Medicine 167 (2007), 551–561, 10.1001/archinte.167.6.551.
23. Gemeinsamer Bundesausschuss (GBA), Richtlinie des Gemeinsamen Bundesauschusses zur Regelung von Anforderungen an die Ausgestaltung von Strukturierten Behandlungsprogrammen nach §137f Abs. 2 SGB V-DMP-Richtlinie. Berlin; 2012.
24. Gershon, A.S., Wang, C., Guan, J., Vasilevska-Ristovska, J., Cicutto, L., To, T., Identifying individuals with physician diagnosed COPD in health administrative databases. COPD 6 (2009), 388–394.
25. National Association of Statutory Health Insurance Physicians (KBV), Programmkostenpauschale; 2015.
26. European Central Bank, Overall inflation in the euro area (HICP); 2015.
27. Decramer, M., Janssens, W., Chronic obstructive pulmonary disease and comorbidities. The Lancet Respiratory Medicine 1 (2013), 73–83, 10.1016/S2213-2600(12)70060-7.
28. German Institute of Medical Documentation and Information (DIMDI), ICD-10-GM Version 2014. Cologne: DIMDI; n.d.
29. Imbens, G.W., Nonparametric estimation of average treatment effects under exogeneity: a review. Review of Economics and Statistics 86 (2004), 4–29, 10.1162/003465304323023651.
30. Hainmueller, J., Entropy balancing for causal effects: a multivariate reweighting method to produce balanced samples in observational studies. Political Analysis 20 (2012), 25–46, 10.1093/pan/mpr025.
31. Austin, P.C., Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples. Statistics in Medicine 28 (2009), 3083–3107, 10.1002/sim.3697.
32. Bertrand, M., Duflo, E., Mullainathan, S., How much should we trust differences-in-differences estimates?. The Quarterly Journal of Economics 119 (2004), 249–275, 10.1162/003355304772839588.
33. Wagstaff, A., Moreno-Serra, R., Europe and central Asia's great post-communist social health insurance experiment: aggregate impacts on health sector outcomes. Journal of Health Economics 28 (2009), 322–340, 10.1016/j.jhealeco.2008.10.011.
34. Bertakis, K.D., Azari, R., Patient gender differences in the prediction of medical expenditures. Journal of Women's Health (2002) 19 (2010), 1925–1932, 10.1089/jwh.2009.1448.
35. Elixhauser, A., Steiner, C., Harris, D.R., Coffey, R.M., Comorbidity measures for use with administrative data. Medical Care 36 (1998), 8–27.
36. Kuo, R.N., Dong, Y.-H., Liu, J.-P., Chang, C.-H., Shau, W.-Y., Lai, M.-S., Predicting healthcare utilization using a pharmacy-based metric with the WHO's Anatomic Therapeutic Chemical algorithm. Medical Care 49 (2011), 1031–1039, 10.1097/MLR.0b013e31822ebe11.
37. Quan, H., Sundararajan, V., Halfon, P., Fong, A., Burnand, B., Luthi, J.-C., et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Medical Care 43 (2005), 1130–1139.
38. Seshamani, M., Gray, A., Ageing and health-care expenditure: the red herring argument revisited. Health Economics 13 (2004), 303–314, 10.1002/hec.826.
39. Sridhar, M., Taylor, R., Dawson, S., Roberts, N.J., Partridge, M.R., A nurse led intermediate care package in patients who have been hospitalised with an acute exacerbation of chronic obstructive pulmonary disease. Thorax 63 (2008), 194–200, 10.1136/thx.2007.077578.
40. Zwerink, M., Brusse-Keizer, M., van der Valk, P.D.L.P.M., Zielhuis, G.A., Monninkhof, E.M., van der Palen, J., et al. Self management for patients with chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews, 3, 2014, CD002990, 10.1002/14651858.CD002990.pub3.
41. Gagnon, Y.M., Levy, A.R., Spencer, M.D., Hurley, J.S., Frost, F.J., Mapel, D.W., et al. Economic evaluation of treating chronic obstructive pulmonary disease with inhaled corticosteroids and long-acting beta2-agonists in a health maintenance organization. Respiratory Medicine 99 (2005), 1534–1545, 10.1016/j.rmed.2005.03.018.
42. Kruis, A.L., Boland, M.R.S., Assendelft, W.J.J., Gussekloo, J., Tsiachristas, A., Stijnen, T., et al. Effectiveness of integrated disease management for primary care chronic obstructive pulmonary disease patients: results of cluster randomised trial. BMJ, 349, 2014, g5392, 10.1136/bmj.g5392.
43. Bischoff, E.W.M.A., Akkermans, R., Bourbeau, J., van Weel, C., Vercoulen, J.H., Schermer, T.R.J., Comprehensive self management and routine monitoring in chronic obstructive pulmonary disease patients in general practice: randomised controlled trial. BMJ, 345, 2012, e7642, 10.1136/bmj.e7642.
44. Bjoernshave, B., Korsgaard, J., Nielsen, C.V., Does pulmonary rehabilitation work in clinical practice? A review on selection and dropout in randomized controlled trials on pulmonary rehabilitation. Clinical Epidemiology 2 (2010), 73–83.
45. Chuang, C., Levine, S.H., Rich, J., Enhancing cost-effective care with a patient-centric chronic obstructive pulmonary disease program. Population Health Management 14 (2011), 133–136, 10.1089/pop.2010.0015.
46. Menn, P., Heinrich, J., Huber, R.M., Jörres, R.A., John, J., Karrasch, S., et al. Direct medical costs of COPD-an excess cost approach based on two population-based studies. Respiratory Medicine 106 (2012), 540–548, 10.1016/j.rmed.2011.10.013.
47. Menzin, J., Boulanger, L., Marton, J., Guadagno, L., Dastani, H., Dirani, R., et al. The economic burden of chronic obstructive pulmonary disease (COPD) in a U.S. Medicare population. Respiratory Medicine 102 (2008), 1248–1256, 10.1016/j.rmed.2008.04.009.
48. Anthonisen, N.R., Connett, J.E., Enright, P.L., Manfreda, J., Lung Health Study Research Group, Hospitalizations and mortality in the Lung Health Study. American Journal of Respiratory and Critical Care Medicine 166 (2002), 333–339, 10.1164/rccm.2110093.
49. Sin, D.D., Man, S.F.P., Pharmacotherapy for mortality reduction in chronic obstructive pulmonary disease. Proceedings of the American Thoracic Society 3 (2006), 624–629, 10.1513/pats.200603-096SS.
50. Langsetmo, L., Platt, R.W., Ernst, P., Bourbeau, J., Underreporting exacerbation of chronic obstructive pulmonary disease in a longitudinal cohort. American Journal of Respiratory and Critical Care Medicine 177 (2008), 396–401, 10.1164/rccm.200708-1290OC.
51. Seemungal, T.A., Hurst, J.R., Wedzicha, J.A., Exacerbation rate, health status and mortality in COPD—a review of potential interventions. International Journal of Chronic Obstructive Pulmonary Disease 4 (2009), 203–223.
52. Fan, V.S., Gaziano, J.M., Lew, R., Bourbeau, J., Adams, S.G., Leatherman, S., et al. A comprehensive care management program to prevent chronic obstructive pulmonary disease hospitalizations: a randomized, controlled trial. Annals of Internal Medicine 156 (2012), 673–683, 10.7326/0003-4819-156-10-201205150-00003.
53. Steuten, L., Vrijhoef, B., Van Merode, F., Wesseling, G.-J., Spreeuwenberg, C., Evaluation of a regional disease management programme for patients with asthma or chronic obstructive pulmonary disease. International Journal for Quality in Health Care 18 (2006), 429–436, 10.1093/intqhc/mzl052.
54. Chandra, D., Tsai, C.-L., Camargo, C.A., Acute exacerbations of COPD: delay in presentation and the risk of hospitalization. COPD 6 (2009), 95–103, 10.1080/15412550902751746.
55. Walters, J.A., Turnock, A.C., Walters, E.H., Wood-Baker, R., Action plans with limited patient education only for exacerbations of chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews(May (5)), 2010, 1–75, 10.1002/14651858.CD005074.pub3 CD005074, John Wiley & Sons, Ltd.
56. Monninkhof, E., van der Valk, P., van der Palen, J., van Herwaarden, C., Partridge, M., Zielhuis, G., Self-management education for patients with chronic obstructive pulmonary disease: a systematic review. Thorax 58 (2003), 394–398, 10.1136/thorax.58.5.394.
57. Rubin, D.B., Formal mode of statistical inference for causal effects. Journal of Statistical Planning and Inference 25 (1990), 279–292, 10.1016/0378-3758(90)90077-8.